Universe Pharmaceuticals Net Debt Growth & History (UPC)
Universe Pharmaceuticals's net debt was −$24.34B for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | −$24.34B | −$694.1M | — |
| 2024 | 2024-09-30 | −$23.64B | −$23.64B | — |
| 2023 | 2023-09-30 | $197,209 | $2.0M | — |
| 2022 | 2022-09-30 | −$1.8M | $2.0M | — |
| 2021 | 2021-09-30 | −$3.7M | $3.7M | — |
| 2020 | 2020-09-30 | −$7.4M | — | — |
Universe Pharmaceuticals quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | −$18.0M | $21.5M | — |
| Q4 2025 | 2025-09-30 | −$24.34B | −$694.1M | — |
| Q2 2025 | 2025-03-31 | −$39.5M | — | — |
| Q4 2024 | 2024-09-30 | −$23.64B | −$23.64B | — |
| Q4 2023 | 2023-09-30 | $197,209 | $2.0M | — |
| Q2 2023 | 2023-03-31 | −$8.9M | $948,892 | — |
| Q4 2022 | 2022-09-30 | −$1.8M | $2.0M | — |
| Q2 2022 | 2022-03-31 | −$9.8M | — | — |
| Q4 2021 | 2021-09-30 | −$3.7M | $3.7M | — |
| Q4 2020 | 2020-09-30 | −$7.4M | — | — |
Universe Pharmaceuticals net debt trends
Over the last five fiscal years, Universe Pharmaceuticals's net debt decreased from −$7.4M to −$24.34B, a change of −$24.33B. The latest reported quarter, Q2 2026, shows −$18.0M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗